
Patients & Caregivers
GEP NE Tumors
Causes
Causes
GEP NE tumors are thought to arise from neuroendocrine cells that grow in an uncontrolled fashion and develop into tumors. What causes these cells to escape the normal brakes that stop them from growing uncontrollably is not entirely understood.
Defective genes often play a role in the development of tumors, and several genes that contribute to the development of GEP NE tumors have been identified. Some of these genes are associated with the inherited disorder, Multiple Endocrine Neoplasia type 1 (MEN1), which increases the risk of developing pancreatic endocrine tumors. Mutations in a gene called MEN1 are involved in causing these tumors to arise.
previous section | next section ›
SEARCH OUR WEBSITES
PRODUCTS
At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resource therapies.
PATIENT STORIES

"My sister died of breast cancer years ago. I'm a cancer survivor-because the battle is a lot different today."
- Carol Lundin
RESEARCH INNOVATION
Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.